1 Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia.
2 Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
3 The Netherlands Cancer Institute, Amsterdam, Netherlands.
4 Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5 Vanderbilt University Medical Center, Nashville, TN, USA.
6 Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
7 AP-HP Dermatology, INSERM U976, Université de Paris, Saint Louis Hospital, Paris, France.
8 Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
9 Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
10 Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.
11 Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
12 Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
13 Department of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australia.
14 Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Services, The University of Manchester, Manchester, UK.
15 Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
16 Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
17 Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@melanoma.org.au.